Recently, research targeting anti ALK antibodies is constantly being explored, and some newly developed monoclonal antibodies against ALK have been confirmed to inhibit the growth of ALK positive tumor cells in in vitro experiments (143). The gene discussed is ALK; the disease is neoplasm.